Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 2:29 PM EDT

Absci (ABSI) Other Operating Expenses (2020 - 2026)

Absci (ABSI) posted Other Operating Expenses of $2.7 million for Q1 2026, up 220.02% sequentially from -$2.3 million in Q4 2025, and down 11.2% YoY from $3.1 million in Q1 2025.

Analysis

Absci (ABSI) Other Operating Expenses (2020 - 2026) Analysis & Trends

Absci has reported Other Operating Expenses for 7 years, with the latest figure at $2.7 million in Q1 2026.

  • Quarterly Other Operating Expenses fell 11.2% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 51.73% YoY) and the FY2025 annual result came in at $6.6 million, down 50.4% from the prior year.
  • Other Operating Expenses improved to $2.7 million in Q1 2026 per ABSI's latest filing, from -$2.3 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $24.8 million in Q2 2023 and troughed at -$2.3 million in Q4 2025.
  • A 5-year average of $4.2 million and a median of $3.4 million in 2024 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2023 and 2025: Other Operating Expenses soared 690.61% in 2023, then slumped 170.28% in 2025.
  • Over 5 years, Other Operating Expenses stood at $3.6 million in 2022, then slipped by 2.84% to $3.5 million in 2023, then dropped by 7.18% to $3.2 million in 2024, then plunged by 170.28% to -$2.3 million in 2025, then jumped by 220.02% to $2.7 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $2.7 million, -$2.3 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70 Mn
Mar 31, 2026 2.73 Mn
Dec 31, 2025 -2.27 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.07 Mn
Dec 31, 2024 834,000.00
Sep 30, 2024 855,000.00
Jun 30, 2024 3.38 Mn
Mar 31, 2024 3.42 Mn
Dec 31, 2023 884,000.00
Sep 30, 2023 813,000.00
Jun 30, 2023 22.13 Mn
Mar 31, 2023 804,000.00
Dec 31, 2022 786,000.00
Sep 30, 2022 804,000.00
Jun 30, 2022 841,000.00
Mar 31, 2022 806,000.00
Dec 31, 2021 859,000.00
Sep 30, 2021 818,000.00